Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies

An Implementation Study

Bibliographic Data

ID15479352
AuthorsSarah Rondeaux (Université Libre de Bruxelles), Tessa Braeckman (0000-0003-2458-383X, Vrije Universiteit Brussel), Mieke Beckwé (Vrije Universiteit Brussel), Natacha Biset (0000-0003-3465-4566, Université Libre de Bruxelles), Joris Maesschalck (Association Pharmaceutique Belge), Nathalie Duquet (Association of Pharmacists Belgium, 1000 Brussels, Belgium), Isabelle De Wulf (Association Pharmaceutique Belge), Dirk Devroey (0000-0002-6083-2998, Vrije Universiteit Brussel), Carine De Vriese (0000-0002-6595-1742, Université Libre de Bruxelles, corresponding author)
Year2022
Volume19
Issue14
Pages8699-8699
Publication date2022-07-17
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph19148699
PMID35886551
OpenAlexW4285732098
LanguageEN
Citations received2
References cited35

The implementation of a new service is often challenging when translating research findings into routine clinical practices. This paper presents the results of the implementation study of a pilot project for a diabetes and cardiovascular diseases risk-assessment service in Belgian community pharmacies. To evaluate the implementation of the service, a mixed method was used that follows the RE-AIM framework. During the testing stage, 37 pharmacies participated, including five that dropped out due to a lack of time or COVID-19-related temporary obligations. Overall, 502 patients participated, of which 376 (74.9%) were eligible for according-to-protocol analysis. Of these, 80 patients (21.3%) were identified as being at high risk for the targeted diseases, and 100 (26.6%) were referred to general practice for further investigation. We presented the limited effectiveness and the key elements influencing optimal implementation. Additional strategies, such as interprofessional workshops, a data-sharing platform, and communication campaigns, should be considered to spread awareness of the new role of pharmacists. Such strategies could also promote collaboration with general practitioners to ensure the follow-up of patients at high risk. Overall, this service was considered easy to perform and feasible in practice but would require financial and external support to ensure its effectiveness, sustainability, and larger-scale implementation

Alternative medicine · Best practice · Business · Computer security · Family medicine · Process management · Protocol (science · Risk assessment · Scale (ratio · Service (business · Sustainability · Chronic Disease Management Strategies · Computer Science · Diabetes Management and Education · Medicine · Pharmaceutical Practices and Patient Outcomes · Marketing · Pharmacy

Tools

Open DOIOpen Access